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 Abstract 
Psf2, a member of the heterotetrameric GINS Complex, plays a role in cell cycle progression and 
maintenance of genomic integrity 
By Laura M Henderson 
July 8, 2010 
Director: Tim Christensen 
Multiple proteins are involved in the complete and accurate replication of the genome during S 
phase of the cell cycle.  At the G1/S phase transition, the heterotetrameric GINS complex is recruited to 
the origin, and facilitates the helicase activity of the Mcm2-7 complex.  Each of the four subunits of the 
GINS complex is essential for proper completion of DNA replication initiation and elongation.  Inaccurate 
replication of the genome results in a multitude of disease states, specifically, cancer. 
 Psf2, a subunit of the GINS complex, has been previously implicated in the segregation of 
chromosomes during M phase.  Additionally, it has been shown that reduced levels of Psf2 in yeast 
results in stalled replication forks and incomplete DNA replication.  However, to date, the function of 
Psf2 in higher eukaryotes has only been studied in tissue culture models.  To provide insight into the role 
of Psf2 in a multicellular organism, we used an in vivo approach to characterize the phenotypes resulting 
from the C-terminal truncation of Psf2 in a homozygous lethal mutant in Drosophila. Through analysis of 
larval brain tissue, salivary tissue, ovarioles, and embryonic tissue, we found the mutant Psf2 displays 
defects during M phase of the cell cycle and DNA replication in endoreplicating cells.  Curiously, the RNAi 
knockdown of Psf2 results in a defect in S phase of the cell cycle, with no effects on M phase.  Therefore, 
we hypothesize that Psf2 plays an essential role in cell cycle progression.  Additionally, removal of the C-
terminal domain is essential for either the correct formation of the GINS complex, or for an external 
interaction, possibly with checkpoint or chromosome segregation proteins. 
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Chapter 1: Introduction 
I. Background 
a. DNA Replication 
In order to maintain viability, each cell must insure accurate and complete replication of its 
genome within a crucial time frame (1).  Deviation from this innate process leads to multiple 
complications for the cell ranging from mutations to death (2).  Eukaryotic cells have developed controls 
to prevent mis-regulation of the cell cycle along with checkpoints to ensure maintenance of genomic 
integrity (3). 
The growth, development and proliferation of a cell rely on the correct progression of the 
eukaryotic cell cycle.  After dividing, a daughter cell enters G1 phase (Figure 1), or the first growth phase 
of the cell cycle.  This phase is characterized by expansion of the cytoplasm and an increase in 
organelles.  During early G1 phase, the ground work for DNA replication is laid down with the 
recruitment of over 20 replication proteins onto specific sites on the DNA.  The process begins with the 
Origin Recognition Complex (ORC), a six subunit complex, which scans the double stranded DNA for AT 
rich sequences, where it binds and recruits other essential 
replication proteins (4).  Also recruited with ORC is Cdc6, 
Figure 1. Schematic diagram of the eukaryotic cell 
cycle. 
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Figure 2. Replication Initiation Complex Formation A) ORC and Cdc6 bind to the origin to 
trigger recruitment of other replication proteins. B) Cdt1 loads Mcm2-7 onto the origin, allowing for 
the binding of Mcm10 and the completion of the Pre-RC. C) GINS and Cdc45 are recruited to the 
origin and bind to Mcm2-7, allowing for the association of over 20 other replication proteins, the 
completion of the Pre-IC and the G1/S phase transition. 
which, in turn, is essential for the association of yet more replication proteins (Figure 2a) (5).  After the 
recruitment of ORC and Cdc6 to the origin, another protein, Dup, is required for the loading of the 
helicase complex.  At the start of G1, Geminin is bound to Dup, inhibiting the activation of helicase 
recruitment.  Once Geminin is degraded, Dup is activated and recruited to the origin (6).  Upon the 
binding of these three proteins, Mcm2-7 is loaded onto the origin (7).  Mcm2-7 is a 6 subunit ring 
hypothesized to contain helicase activity (8).  After Mcm2-7 is recruited to the origin, another mini-
chromosome maintenance protein, Mcm10, also joins, creating the Pre-Replication Complex (Pre-RC) 
(Figure 2b) (9). 
 
 
 
A 
C 
B 
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The formation of the Pre-RC marks the licensing, or sufficient loading of the Mcm2-7 helicase 
complex for completion of replication only once, of the origin, and precedes the recruitment of multiple 
other replication proteins (6).  Cyclin dependent kinases (CDKs) and Dpb4 dependent kinases (DDKs) are 
constantly present in the nucleus of the cell to regulate cycle progression.  Specific CDKs and DDKs are 
responsible for the phosphorylation of different proteins throughout the process of replication (7, 8). 
 After formation of the Pre-RC, Cdc45 is recruited to the origin following phosphorylation of the 
Mcm2-7 complex by the Cdc7-Dbf4 complex (9, 6, 11).  These two events happen in synchrony, and are 
immediately followed by the recruitment of the GINS complex which is facilitated by Mcm10 (12).  The 
GINS complex is essential for the progression of DNA replication, and is predicted to increase the 
helicase activity of the Mcm2-7 proteins (13).  After the recruitment of these proteins, the pre-Initiation 
Complex (Pre-IC) has formed, and the polymerases are recruited to complete the Replisome Progression 
Complex (RPC) (Figure 2c) (14). In order to efficiently replicate the entire genome, two pre-ICs are 
formed at the origin, allowing replication to proceed in a bidirectional and semiconservative fashion (6).  
Following accurate and complete replication of the genome, the cell continues into G2 phase or 
the second growth phase of the cycle where the cell prepares for cytokinesis.  At the G2 to M phase 
transition, Cdc25 is activated, and the cell transitions into mitosis (15).  During mitosis, the 
chromosomes in the nucleus condense, align along the metaphase plate, and sister chromatids separate 
to the poles of the cell in preparation for cytokinesis (Figure 1). 
b. GINS Complex 
 The GINS Complex, whose name is derived from the Japanese Go, Ichi, Ni, San for 5-1-2-3, is a 
highly conserved heterotetrameric complex composed of the subunits Sld5, Psf1, Psf2, and Psf3 (Figure 
3) (1).  Originally discovered in yeast, the GINS complex is required for both replication initiation and 
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Figure 3. Crystal Structure of the Human GINS 
Complex (top) Alpha helices and beta sheets of each of the 
four subunits of GINS, arranged in the ring structure. 
(bottom) Surface representation of the ring shaped complex.  
Purple=Psf2, Blue=Sld5, Green=Psf1, Yellow=Psf1 (18) 
elongation (13).  Although GINS is shown to increase the helicase activity of the Mcm2-7 complex, it is 
also implicated in enhancing the polymerase activity of Pol-α and Pol-ε (1, 16).  Through its interactions 
with Mcm2-7 and Cdc45, GINS is a member of the Replisome Progression Complex that moves with the 
replication fork during elongation (9, 14).  Each of the four subunits is required for the association of the 
complex, and the absence of one subunit leads to a stalled replication fork (17). 
                                               
 
 
 The four subunits of the Complex are divided into pairs based on their structural similarity: 
Psf1-Sld5 and Psf2-Psf3.  Each subunit consists of multiple alpha helices responsible for the interactions 
between subunits, followed by intermittent beta sheets hypothesized to interact with other replication 
proteins (17).  The essential function of the GINS Complex is highly conserved and GINS homologues 
have been identified in Archea as well.  In addition to interacting with the MCM proteins, the Archael 
GINS complex also shares many structural similarities to the eukaryotic GINS complex (19).  Although 
archeal GINS is composed of only two subunits, GINS 23 and GINS 15, the structural similarity of each of 
 
Figure 4. Crystal structure of 
Psf2 (18). 
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the archeal subunits mirrors that of the eukaryotic subunits that are paired based on structural 
similarity: Psf2-Psf3 and Psf1-Sld5 respectively (19).     
Psf2 (Partner of Sld-five 2) has been shown to interact with Sld5 and Psf3 in forming the ring-
shaped structure of the GINS complex (Figure 4) (21).  In addition to its role within the Complex in DNA 
replication, Psf2 has also been implicated in chromosome segregation during M phase of the cell cycle in 
S. pombe and human tissue cultures (4).  Additionally, levels of Psf2 have been shown to be upregulated 
in liver cancer cells, and Psf2 is shown to interact with Chk2, a DNA damage and a G2-M checkpoint 
protein, in humans (22, 23, 24). Finally, Psf2 has demonstrated a tissue specific role affecting eye 
development in Xenopus (25).  Despite the previous research on Psf2, there are still many remaining 
questions into the function of Psf2.  Primarily, previous research has formed a connection between 
many of these other defects, without specifically studying the function of the protein itself.  Additionally, 
all of the previous research in eukaryotes has been performed in vitro as opposed to in vivo. 
In order to further characterize the role of Psf2 we utilized a homozygous lethal mutant in 
Drosophila melanogaster.  Utilizing a p-element insertion into the psf2 allele leading to a 61 amino acid 
truncation of the protein could provide insight into the role of psf2 in vivo.  Additionally, this C-terminal 
truncation removes the last, highly conserved, alpha helical domain responsible for the Psf2-Psf3 
interaction during GINS complex formation (Figure 5) (19).  Since each subunit is essential for proper 
formation of the GINS Complex, it is hypothesized that this C-terminal truncation would lead to 
malformation and inactivation of the GINS complex.  Drosophila has already been established as a model 
organism for higher eukaryotes (26).   Additionally, Drosophila has a fully sequenced genome and a vast 
availability of tools and techniques, making it an ideal organism for use as a research tool.  In addition to 
observation of phenotypes in varying tissues in a mutant psf2 fly, we also are utilizing yeast two hybrid 
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analysis to provide insight into the role of Psf2 throughout DNA replication and elsewhere in the cell 
cycle.  
 
 
II. Specific Aims 
 Defects in the assembly and progression of the replication machinery provide the basis for many 
disease states, specifically, cancer (21).  Additionally, many of these proteins have separable roles 
throughout the cell cycle in tissue differentiation, cell cycle checkpoints, and chromatin dynamics (11, 
21).  Increasing our knowledge of the role of these replication proteins throughout the cell cycle could 
prove beneficial in the treatment of many diseases. 
 The characterization of psf2 will likely provide insight into its specific role within the GINS 
complex and elsewhere in the cell.  I utilized Drosophila melanogaster as a model organism to address 
the following hypothesis regarding GINS and Psf2: 
 The Drosophila Psf2 protein plays a role in DNA replication. 
I addressed this hypothesis through the following specific aims: 
Specific aim #1: Characterize mutant psf2 phenotype  
Figure 5. Structure of the Psf2 protein.  P-element insertion in 2nd 
conserved region leads to 61 AA truncation and removal of the 
last alpha helical region 
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 In order to test the role of Drosophila Psf2 throughout the cell cycle, I utilized a homozygous 
lethal psf2 mutation to observe phenotypes within multiple tissues.  First, observation of the larval brain 
tissue provided insight into the role of psf2 in normal cycling cells.  Second, observation of the larval 
salivary tissue and ovarioles allowed for the assessment of a possible role for psf2 in endoreplicating 
tissue.  Finally, observation of Drosophila embryos allowed for detection of defects in cell cycle 
progression and chromatin dynamics.  
Specific aim #2: Identify interactions between psf2 and other replication proteins 
 Psf2 has been previously implicated as a member of the GINS Complex which associates with the 
pre-RC during DNA replication initiation. The exact mechanism of the recruitment and association of 
these proteins is still unknown.  Using the yeast two-hybrid system, I tested for interactions between 
Psf2 and other replication proteins in Drosophila.   
Specific aim #3: Deplete levels of psf2 and observe phenotypes 
 The psf2 mutant fly contains a p-element insertion truncating the last 61 amino acids.  In 
addition to observing the phenotypes in this truncated mutant, I utilized RNAi knockdown using the 
Gal4-UAS system to deplete levels of Psf2 in different tissues and observe the phenotypes.   
III. Materials and Methods 
Genomic DNA extraction: First, 30 wildtype anesthetized flies were placed in a 1.5 mL Eppendorf tube 
(Fisher™) and stored at -80oC.  When ready for the extraction, 200 µL Buffer A (Table 1) was added and 
tissue was ground using a disposable tissue grinder.  Then, 200 µL additional Buffer A was added, and 
flies were ground until only cuticles remained.  Next, samples were incubated at 65oC for 30 minutes.  
After 30 minutes, 800 µL Buffer B (Table 2) was added, mixed by inverting the tube and incubated for 1 
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hour on ice.  Next, samples were centrifuged at 12,000 rpm for 15 minutes at room temperature.  The 
supernatant was then transferred into a new 1.5 mL Eppendorf tube, and 600 µL isopropanol was added 
to each sample and mixed.  The sample was then centrifuged at 12,000 rpm for 15 minutes at room 
temperature.  Next, the supernatant was discarded, and the pellet was washed with 70% ethanol.  The 
majority of the ethanol was removed with a p200 pipette, and the sample was allowed to air dry until all 
the ethanol was removed.  Genomic DNA was resuspended using dH20 and stored at -20
oC. 
Component Concentration 
Tris-Cl (pH 7.5) 100 mM 
EDTA 100 mM 
NaCl 100 mM 
SDS 0.5% 
                                      Table 1. Components of Buffer A stored at room temperature. 
Component Amount Added 
5 M Potassium Acetate 200 mL 
6 M Lithium Chloride 500 mL 
                                                    Table 2. Components of Buffer B stored at 4oC. 
PCR:  Psf2 cDNA was amplified using Platinum Pfx DNA polymerase (Invitrogen™).  Amounts added can 
be seen in Table 3.  To start, components were denatured at 94oC for 2 minutes followed by 35 cycles 
each with 15 seconds of denaturation at 94oC, annealing at 57oC for 30 seconds and a 1 minute 
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extension time.  Primers used are displayed in Table 4.  Genomic DNA was amplified using psf2 2000+ 
genomic topo and psf2 minus stop (Integrated DNA Technologies™), and cDNA was amplified using psf2 
plus stop codon and psf2 start topo (Integrated DNA Technologies™).  PCR products were tested with gel 
electrophoresis in a 1% agarose gel run at 135 V for 30 minutes.  
Component (Invitrogen™) Amount Added 
(µL) 
5X Pfx Amplification Buffer 5  
Primers (10µM ) 1.5 of each 
dNTP (10µM) 1.5 
MgSO4 (10mM) 1 
Psf2 CDNA 1 
Platinum Pfx  1 
dH20 To 50 µL 
                                                    Table 3. Components added for PCR 
Primer Name (Integrated DNA 
Technologies™) 
Sequence 5’—3’ 
Psf2 Start topo CACCATGTTCCCGCATTTGTTTTG 
Psf2 plus stop codon TCACTGAGAAAACAGAGAGTTACTGTTC 
10 
 
Psf2 2000+ genomic promo topo CACCCGTATATAGTTTAAAATTGAGATCACTTTTG 
Psf2 minus stop codon CTGAGAAAACAGAGAGTTACTGTTCGG 
      Table 4. Primers used to amplify Psf2 
Cloning Psf2 into Plasmids: After confirming the size of the PCR product, the insert was first cloned in 
the pENTr-d-TOPO entry vector (Invitrogen™).  Amounts added to 1.5 mL Eppendorf tube are displayed 
in Table 5.  The Cocktail was incubated for 5 minutes at 25oC, followed by the addition of 50µL 
competent e.coli cells to the vector mixture and placed on ice for 30 minutes.  Next, cells were heat 
shocked for 30 seconds at 42oC, followed by the addition of 100µL LB broth and a 45 minute incubation 
period at 37oC.  After incubation, cells were plated on LB media supplemented with kanamycin to select 
for the p-ENTr-d-TOPO vector (Invitrogen™) and incubated overnight at 37oC.  After 14-24 hours, 
colonies were selected and grown in LB broth overnight.  DNA was isolated using Minipreps™ 
(Promega™) and sequenced to confirm cloning of insert into the entry vector. 
After sequencing, the insert was cloned from the entry vector to one of three destination vectors: pGAD 
T7, pGBK T7 or pTWF using LR Clonase (Invitrogen™).  Amounts added to 1.5mL Eppendorf tube are 
displayed in Table 6.  The Cocktail was incubated for 1 hour at room temperature, followed by 
transformation into e.coli as seen above.  The Reaction was plated on LB media supplemented with 
ampicillin to select for the pGBK (Clonetech™), pGAD (Clonetech™), and pTWF (Murphy™) vectors 
followed by incubation overnight at 37oC.  After 14-24 hours, colonies were selected and grown in LB 
broth overnight.  DNA was isolated using Minipreps™ (Promega™) and sequenced to confirm cloning on 
insert into the destination vectors. 
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 Component Amount Added (µL) 
PCR Product 2 
p-ENTr-d-TOPO salt solution (Invitrogen™) 1 
p-ENTR-d-TOPO vector enzyme (Invitrogen™) 1 
dH20 2 
   Table 5. Components added for entry vector cloning 
Component Amount Added (µL) 
p-ENTr-d-TOPO vector containing insert 3 
Destination vector (pGADT7, pGBKT7, pTWF) 3 
LR Clonase enzyme (Vortexed) (Invitrogen™) 2 
LR Clonase Buffer (Invitrogen™) 3 
   Table 6. Components added for destination vector cloning. 
Transgenic Fly Cross: First, genomic Psf2 was cloned into the pTWF (Murphy™) vector using LR clonase 
reaction seen above.  The resulting vector with Psf2 cloned into the gateway cassette was mailed to Best 
Gene Inc. for generation of the transgenic fly as seen in Figure 6.  Balancer chromosomes, depicted as 
CyO, Gla, and sb, are essential for preventing homologous recombination, and persistence of a true 
breeding stock.  These balancer chromosomes are recessive lethal, allowing for the persistence of the 
heterozygous mutation.  Additionally, the balancer chromosome contains multiple inversions to prevent 
12 
 
recombination during cross over events.  This allows for the persistence of the true breeding, 
heterozygous stock. 
 
 
In stocks with persisting red eyes, the following cross was completed and stocks were monitored to see 
if the CyO wing phenotype was lost (Figure 7). 
Figure 6. Generation of transgenic fly 
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Homozygous Mutant Fly Cross: Generation of the homozygous Psf2 fly was performed as seen in Figure 
8. 
 
 
w ; Psf2/GFP, CyO females were fed with yeast paste overnight, followed by embryo collection on grape 
agar plates.  After 6 hours, embryos were observed under a dissecting microscope with UV filter where 
non glowing embryos (psf2/psf2) were selected and placed on a grid on grape agar (Genesee Scientific™) 
Figure 7. Generation of rescue fly 
Figure 8. Generation of homozygous mutants 
14 
 
plates for observation.  Additionally, slightly glowing embryos were also collected and placed in a grid on 
grape agar plates for observation to act as a control. 
Polytene Chromosomes:  3rd instar wandering larvae were isolated and placed in a dual concavity slide 
with 50 μL 1X PBS pH 7.2 with 1% PEG 8000 in one well.  Salivary glands were dissected out using 
Dumoxel™ Tweezers #5 (Electron Microscopy Sciences™) and moved to the second well into a solution 
of 50% acetic acid, 2-3% lactic acid, 3.7% formaldehyde and fixed for 2 minutes.  Salivary glands were 
then transferred using a p20 pipette to a cleaned microscope slide where they were covered with a 
siliconized coverslip (coverslips prepared by dipping into Sigmacote™ (Sigma™)).  Next, a piece of filter 
paper was placed on top of the slide, and the salivary tissue was spread using a circular tapping motion 
with a pencil for 2 minutes.  Once spread, a piece of filter paper was sandwiched between the spread 
salivary tissue and a clean microscope slide, and placed in a machinist vice.  Pressure was applied using a 
torque wrench to 15 nM for 2 minutes.  The slide was then removed from the vice, and placed in liquid 
nitrogen for 1 minute.  The siliconized coverslip was removed using a razorblade, and the slide was 
placed in ethanol for 30 seconds.  After 30 seconds, the slide was removed from the ethanol and placed 
in a centrifuge to air dry.  Once dry, the slide was stained and mounted with 7mL of Vectashield™ 
(Vector™) with DAPI and stored at 4oC. 
Embryo Collection and microscopy: Female fly stocks were isolated and fed overnight with a yeast paste 
made from 1:1 mixture of active dry yeast and dH20 overnight followed by embryo collection on grape 
agar plates.  After 5 hours, embryos were collected on the grape agar plate using dH20 and a paintbrush.  
The embryos were removed from the grape plate using a p1000 pipette and placed in a mesh basket.  
The mesh basket was made by cutting the bottom off of a 2 mL cryogenic tube and placing a piece fine 
mesh over the top.  Next, the mesh basket was placed under a dissecting microscope, and a 50% bleach 
solution in dH20 was pipetted into the mesh basket, while monitoring the embryos through the 
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dissecting microscope for removal of the chorion by the 50% beach solution.  Once the dorsal 
appendages disappeared from the posterior of the embryos, the embryos were then washed with an 
Embryo solution (7% NaCl, 0.5% Triton X-100, dH2O) followed by washing with dH20.  Next, embryos 
were transferred to 5mL glass vials where they were washed off of the mesh using 1 mL of Heptane.  
Next, 1 mL of Methanol was added to the vial, followed by 25 seconds of vigorous shaking to devitilinize 
the embryos.  After all the embryos settled to the bottom of the vial, the upper Heptane layer was 
removed, and embryos were stored in Methanol at 4oC if desired.  After optional storage, the methanol 
was removed, and embryos were rehydrated with PBTA (1X PBS, 1% BSA, 0.02% Sodium Azide, 0.05% 
Triton X-100) for 15 minutes on a rotator.  Next, embryonic DNA was stained with a 1μg/mL DAPI 
solution in PBTA at room temperature for 5 minutes in the dark.  Following 3X 5 minute washes and 1 
hour wash with PBTA, embryos were mounted using two Lifterslip™ (Thermo Scientific™) slides using 
Vectashield™ (Vector™) and imaged.  Microscopy was performed using an Olympus IX81 Motorized 
Inverted Microscope with Spinning Disk Confocal, and images were analyzed using Slidebook™ software. 
Brain Squashes/Mitotic Indices:  3rd instar wandering larvae were isolated and placed in a dual 
concavity well with one side filled with 1X PBS pH7.2 with 1% PEG 8000.  Brains were dissected out and 
moved to the second well and placed in a hypotonic solution of 0.5% Sodium Citrate for 10 minutes.  
The larval brains were then transferred to a clean microscope slide using a p20 pipette, and covered 
with a siliconized coverslip (generated by dipping a glass coverslip into Sigmacote™ (Sigma™)).  The brain 
was carefully sandwiched between the cleaned slide, filter paper and a second slide, placed in the 
machinist vice with 15 nM of pressure applied using a torque wrench.  After 2 minutes, the slide was 
removed and placed in liquid nitrogen for 1 minute.  The silconized coverslip was removed using a 
razorblade, and the slide was placed in ethanol for 30 seconds.  After removing from the ethanol, the 
slide was placed in a centrifuge to air dry.  Once dry, the brain was mounted with 7mL of Vectashield™ 
(Vector™) with DAPI and stored at 4oC. 
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Mitotic indices were performed by selecting 10 well populated random fields of view for each brain 
squash and imaged using 60X magnification on the Olympus IX81 Motorized Inverted Microscope with 
Spinning Disk Confocal.  The total number of nuclei were counted for each field of view and divided by 
the number of mitotic figures per the same field of view.  Statistical analysis was performed using 
Minitab™ Statistical Software. 
Antibody Staining:  Embryos were collected using the protocol above for embryo collection.  However, 
the embryos were extracted from the grape plates (Genesee Scientific™) after 10 hours, as opposed to 5 
hours.  The longer collection time allowed embryos to develop past the early embryo stage into the late 
stages of embryonic development.  After rehydrating with PBTA for 15 minutes on a rotator, embryos 
were stained with 1µg/ml rabbit antibody to phosphor H3 (Millipore™) and incubated at room 
temperature on a rotator for 5 hours.  Following the 5 hours, the embryos were washed 3X with PBTA, 
and placed on the rotator in 4oC overnight in PBTA.  Next, the embryos were stained with 1 µg/ml of 
Anti-Rabbit antibody to phospho H3 conjugated to a fluorescein (Millipore™) and incubated for one hour 
in the dark at room temperature on a rotator.  Embryos were then washed 3X in PBTA followed by a 1 
hour wash in PBTA.  Next, DNA was stained using a 1μg/mL DAPI solution in PBTA for 5 minutes, 
followed by 3X 10 minute washes and a 1 hour wash in PBTA.  Embryos were moved to a clean a 
Liftaslide®(Thermo Scientific™) and mounted using Vectashield® (Vector™).  Microscopy was performed 
using a Olympus IX81 Motorized Inverted Microscope with Spinning Disk Confocal using GFP and DAPI 
filters followed by analysis using Slidebook™ software. 
Ovary/Follicle Dissection and Imaging: Female fly stocks 3-7 days post eclosion were fed for 2 days 
with a 1:1 mixture of active dry yeast and dH20.  Random female flies were selected, and ovaries were 
dissected out in a dual concavity slide in one well with 50 μL 1X PBS.  Ovarioles were teased apart using 
a needlepoint tool, moved to the second well, and fixed for 20 minutes in a 4% Formaldhyde in PBX (PBS 
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with 1% Triton X-100).  After fixing, ovaries were moved to a new well and stained for 5 minutes in a 1 
µg/ml DAPI in PBS.  Ovaries were then washed 3X in PBX, followed by a 1 hour PBX wash, and 3X 10 
minute washes in PBX.  Ovaries were then moved using Dumoxel™ Tweezers #5 (Electron Microscopy 
Sciences™) to a clean Lifterslip™ (Thermo Scientific™), mounted with Vectashield™ (Vector™) and 
imaged using confocal optical sectioning microscopy. 
EdU incorporation assays:  3rd instar wandering larvae were isolated and placed in a dual concavity slide 
in Grace’s cell culture solution, and brains were removed from the larvae and cleaned using Dumoxel™ 
Tweezers #5 (Electron Microscopy Sciences™).  An equal volume of 200 mM of the Click-it EdU reaction 
solution (Invitrogen™) in DMSO was added to the well and brains were incubated in the dark at room 
temperature for 30 minutes.  Following incubation, the liquid was removed from the well using a p200 
pipette and the brains were washed 2X with 1X PBS.  The 1X PBS was then removed, and brains were 
fixed in 3.7% Formaldehyde solution in PBS for 15 minutes followed by 2X washes in 1X PBS.  Next, 
brains were permeablized using 0.1% Triton-X in PBS for 15 minutes.  Brains were then incubated for 30 
minutes in the Click it® Reaction (Invitrogen™) cocktail followed by 2 washes with the reaction buffer 
per manufacturer’s instructions.  The rinse buffer was removed and brains were stained using 0.1% 
Hoeschtt 3342 in dH20 for 18 minutes.  The stain was removed from the well and brains were washed 2X 
using PBS.  Brains were then mounted on a clean Lifterslip™ (Thermo Scientific™) using Vectashield™ 
(Vector™).  Imaging was completed using the Olympus IX81 Motorized Inverted Microscope with 
Spinning Disk Confocal using GFP and DAPI filters. 
Yeast Two-Hybrid Analysis: Protocol performed as from Apger et. Al. (41). 
Chapter 2: Results 
IV. Results 
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Psf2 homozygous mutant arrest in M phase during the late embryo/1st instar larval developmental 
stage 
In order to confirm the p-element insertion in the psf2 mutant fly line produced inviable homozygous 
offspring, psf2 mutant fly strains were crossed to a GFP tagged fly line.  Psf/CyO, GFP larvae were 
isolated as a true-breeding stock.  Female psf2/CyO, GFP adult flies were fed with yeast paste overnight, 
and embryos were collected on grape agar plates for analysis.  Twenty five embryos from psf2/psf2 
embryos (non-glowing embryos) and wildtype embryos were placed in a grid formation.  After 48 hours, 
all of the wildtype embryos hatched and developed into 2nd instar larvae, while only two of the psf2/psf2 
embryos hatched.    Of those that hatched, all of the 1st instar larvae arrested immediately.  Therefore, 
we confirmed the homozygous lethality of the psf2 mutant fly, and determined the arrest point at the 
late embryo/1st instar larval transition. 
Psf2/Psf2 arrests in M phase of the cell cycle 
After determining the late embryonic arrest point, homozygous psf2 embryos were collected to 
determine the phase of the cell cycle in which they arrested.  Mutant and wildtype embryos were 
stained with a rabbit antibody to phosphoH3.  A secondary anti-rabbit antibody conjugated with a 
fluorescein was added for detection of M phase cells and DAPI to stain DNA.  After imaging, psf2 
homozygous mutant embryos displayed more cells in M phase, confirming an M phase arrest point in 
late embryonic development (Figure 9). 
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Flies heterozygous for the psf2 mutation display M phase delay in 3rd instar larval brain tissue 
Since the psf2 homozygous mutant arrests in M phase, we wanted to examine the cell cycle progression 
of the normal cycling larval brain tissue.  Wildtype and psf2/CyO mutant 3rd instar wandering larval 
brains were dissected and stained with DAPI for analysis.  An average mitotic index for wildtype larval 
brains was 0.37% while an average mitotic index for psf2 heterozygous mutant was 2.4%.  T-test analysis 
indicates a statistically significant difference between mitotic indices of wildtype and mutant flies with a 
p-value of 0.004 (Figure 10). 
 
 
Psf2/Psf2 +/+ 
Figure 9.Homozygous Mutant Late 
Embryonic Arrest Visualization. Psf2 
homozygous mutant embryos were 
collected and stained with antibody to 
phosphor H3 identifying cells in M phase 
(green).  Additionally, embryos were 
stained with DAPI (blue) to identify cells in 
interphase.  Observation of 10 hour 
embryos shows increased cells in M phase 
in psf2/psf2 (left) versus wildtype (right). 
Figure 10. Mitotic Index for Psf2 
Heterozygous Mutant.  Wildtype and psf2/+ 
3rd instar wandering larval brains were 
dissected and squashed for observation.  The 
number of mitotic figures were counted and 
divided by the number of cells in interphase 
to calculate the mitotic index.  Psf2/+ larval 
brains (left) displayed a mitotic index 
significantly higher than that of wildtype. 
(right).   
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Psf2 heterozygous mutant displays increased aneuploidy and defects in chromosome dynamics in 3rd 
instar larval brain tissue 
Previously, psf2 has been implicated in chromatin segregation during M phase (4).  Therefore, we 
examined the mutant’s mitotic figures in the larval brain tissue compared to wildtype.  The psf2/CyO 
mutant displayed more aneuploid cells (Figure 11a) compared to wildtype, along with defects in 
chromosome dynamics, such as arm length and broken chromosomes (Figure 11b). 
 
Psf2 heterozygous mutant displays an M phase delay visible using EdU S phase staining 
After observing an M phase delay, we wanted to confirm a role for psf2 in either M or S phase of the cell 
cycle. Therefore, we incorporated an azide tagged thymadine analogue (EdU) into 3rd instar larval brain 
tissue to indicate cells undergoing DNA replication.  The psf2/CyO mutant shows fewer cells 
1 
2 
 
A 
B 
Figure 11. Defects Chromosome Dynamics Visualized in 
Larval Brains A) psf2/+ displays an increase in aneuploid cells 
(left). Wildtype Drosophila brains display the correct number, 8, 
chromosomes (right). B) Psf2/+ mutant displays defects in 
chromosome dynamics.  Many of the chromosomes displayed 
broken arms (see arrows on left), along with condensations defects 
(see bottom right).   
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incorporating the EdU molecule into the genome, confirming the M phase delay in larval brain tissue 
(Figure 12). 
 
Psf2 mutant displays defects in cell cycle progression and chromatin dynamics visible in early embryos 
Drosophila early embryo cell cycles occur in a syncytium with few checkpoint controls (28).  Since the 
psf2 mutant displays an M phase delay, we wanted to observe the progression of the cell cycle with little 
inhibition by checkpoint controls.  Homozygous mutant psf2 and wildtype 5 hour embryos were 
collected on grape agar plates and stained with DAPI.  After imaging, wildtype embryos nuclei appear 
synchronized in one phase of the cycle, while psf2 mutant embryos display multiple nuclei in each phase 
of the cell cycle (Figure 13a).  In addition to the asynchrony of nuclei in the psf2 mutant, wildtype 
embryos displayed a uniform distribution of cells, while the psf2 mutant displayed multiple gaps where 
cells died, and dropped out of the periphery (Figure 13b). 
Additionally, the migration of the nuclei to the periphery allows for easy examination of the chromatin 
dynamics of the nuclei progressing through M phase.  Therefore, we closely examined the mitotic 
figures of both the psf2 mutant and wildtype nuclei to confirm any defects in mitosis.  Upon 
+/+ Psf2/+ 
 
Figure 12. EdU Incorporation in psf2 Heterozygous 
Larval Brains.  Psf2/+ displays M phase delay visible in 
3rd instar wandering larval brains.  Use of EdU to 
incorporate an azide tagged thymadine analogue to 
image cells in S phase (green), to compare DAPI stained 
cells elsewhere in the cell cycle (blue). Psf2/+ mutant 
displays less cells incorporating the EdU compared to 
wildtype, confirming the M phase delay. 
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examination, psf2 mutant chromosomes formed anaphase bridges (Figure 13c).  
 
           
 
Psf2/Psf2 
+/+ 
+/+ 
Psf2/Psf2 
Figure 13. Defects Visualized in 
Homozygous psf2 Early Embryos.  a) 
Psf2/psf2 embryos displays  asynchrony 
in the synctial cell cycle (left). b) 
Wildtype embryos (right) display a 
uniform distribution of cells in the 
periphery while psf2/psf2 embryos do 
not have a uniform distribution with 
cells dropping out of the periphery (left).  
c) Psf2/psf2 embryos display anaphase 
bridges.  
A 
B 
C Psf2/Psf2 Psf2/Psf2 
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Psf2 mutant fly displays defects in DNA replication in endocycling tissues  
Psf2 is one of four subunits in the GINS complex, which plays a role in enhancing helicase activity of the 
Mcm2-7 complex during DNA replication, initiation, and elongation (13).  Additionally, knockdown of 
psf2 has been previously shown to lead to stalled replication forks and a decrease in replication of the 
genome (4).  Therefore, we wanted to test the psf2/Cyo mutant fly for defects in DNA replication.  To do 
this, we examined the polytene salivary tissue of the 3rd instar wandering larvae in wildtype and psf2 
stocks.  Endocycling tissues display a unique cell cycle with one growth phase, G, followed by a normal S 
phase of the cycle and no subsequent cytokinesis (29).  Endocycling tissues, or polytene tissues, are 
polyploid and contain highly banded chromosomes containing small amounts of heterochromatin, and 
are easily visualized for gene localization (29).  Since psf2 is hypothesized to play a role in replication, 
examination of the endocycling tissues, which only go through S phase and G phase, could provide 
insight into the role of psf2 within the cell cycle (29).   Salivary tissue was removed from the larvae and 
stained with DAPI for analysis.  Compared to wildtype, psf2 heterozygous mutants displayed smaller 
polytene chromosomes, indicating a defect in DNA replication in endoreplicating tissue (Figure 14). 
 
+/+ Psf2/+ 
Figure 14. Heterozygous psf2 
Mutants Display Defects in 
Salivary Tissue.  Psf2/+  3rd instar 
wandering larval salivary tissue 
displays smaller polytene 
chromosomes (left) compared to 
wildtype salivary tissue (right). 
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Previous data implicates psf2 in chromosome segregation and interaction with other proteins involved 
in chromosome dynamics (4).  Since our in vivo observation also implicated psf2 playing a crucial role in 
the endoreplicating salivary glands, we also wanted to analyze the nurse cells within the ovarioles which 
are also endoreplicating tissue.  Female wildtype and heterozygous psf2 mutant flies were fed yeast 
paste overnight for 2 days, and random females were selected for dissection of their ovaries.  Ovarioles 
were teased apart and fixed, followed by staining with DAPI.  After imaging, the psf2 mutant nurse cells 
displayed varying chromosome size, indicating a defect in DNA replication (Figure 15c).  
Additionally, nurse cell chromosomes undergo multiple stages with varying chromosome characteristics.  
During stage 4 of development, nurse cell chromosome persists in a polytene state, similar to those seen 
in the salivary glands.  At stage 5, the chromosomes condense into a characteristic “5 blob” stage, 
followed by decondensing of the chromosomes at stage 6 (Figure 15a) (30).  Examination of the wildtype 
and psf2/CyO mutant ovaries show a defect in the progression of chromosome from condensed state at 
stage 5 to the decondensed state at stage 6 (Figure 15b).  Chromosomes in the psf2/CyO mutant appear 
less condensed, similar to the polytene state of stage 4, suggesting a role for psf2 in decondensation of 
the nurse cell chromosomes. 
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Stage 5 Stage 6 
+/+ +/+ 
 
Psf2/+ 
B 
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Knockdown of Psf2 displays an S phase delay 
 Since the truncated Psf2 displays an M phase delay, we wanted to confirm that the p-element 
insertion caused a null mutation.  Existence of a fully sequenced Drosophila genome is pivotal in many 
modern research techniques.  This luxury has allowed for the creation of an RNAi system that knocks out 
individual proteins in a tissue specific manner.  Utilizing the GAL4-UAS system, the GAL4 activation 
domain is inserted behind a tissue specific enhancer region (31).  Activation of the GAL4 domain with 
the presence of the UAS elements triggers recruitment of RNA polymerase, and the transcription of the 
RNAi construct (31).  This leads to knockdown of proteins within the specific tissue.  Use of this 
technique allows for in vivo analysis of fully depleted proteins that would normally be impossible due to 
lethality (31).    Therefore, we knocked down levels of Psf2 in normal cycling larval brains using RNAi to 
observe the phenotype.  First, brains were dissected out of 3rd instar wandering larvae with depleted 
levels of Psf2, squashed and stained with DAPI for observation.  Surprisingly, RNAi knockdown of Psf2 
displays an S phase delay quantified using mitotic indices (Figure 16a).  Wildtype larval brains had an 
average mitotic index of 0.38% while RNAi knockdown lead to an average mitotic index of 0.04%.  T-test 
analysis revealed a statistically significant difference with a p-value of 0.02.  In order to confirm the S 
Figure 15. psf2 Heterozygous Mutants Display Defects in Ovariole 
Development. a) Nurse cell chromosomes undergo condensation into a 
characteristic 5 blob apparence at stage 5, followed by decondensation in 
stage 6.  B)Psf2/CyO female flies display normal polytene chromosomes in 
stage 3 of the developing nurse cell within the ovaries (data not shown).  At 
stage 4, psf2/CyO displays a normal condensed “5 blob” stage compared to 
wildtype (right column).  During stage 5, chromosomes decondense from the 
“5 blob” stage.  Psf2/CyO female ovaries display defects in the condensation 
state, where they appear more polytene compared to wildtype (left column). 
c) Psf2/CyO nurse cells appear in various shapes and sizes indicating defects in 
DNA replication (see arrows).  Additionally, some nurse nuclei were unable to 
correct defects, and dropped out (see triangles). 
C 
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phase delay of the cell cycle, the 3rd instar larval brains were treated with EdU for incorporation into 
cells undergoing S phase of the cell cycle.  Whole brains were then stained with a fluorescently tagged 
azide and Hoescht for visualization.  After imaging, the RNAi flies displayed more cells incorporating EdU 
compared to wildtype, confirming the S phase delay when levels of Psf2 are knocked down (Figure 16b).   
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Psf2 interacts with Sld5 and Mcm2 confirmed using Yeast Two-Hybrid Analysis 
 The GINS complex is a ring shaped structure composed of 4 subunits: Psf1, Psf2, Psf3, and Sld5.  
Previous data confirmed the order of subunits in the ring as Sld5, Psf1, Psf3 and Psf2: showing an 
interaction between Sld5 and Psf2, and Psf2 and Psf3 (17).  In order to confirm the interaction with Sld5, 
cDNA from psf2 and sld5 were cloned into the pGADT7 and pGBKT7 vectors in order to fuse Psf2 and 
Figure 16. RNAi Knockdown of Psf2 Leads to an S 
Phase Delay.  a) 3rd instar larval brains were squashed and 
stained with DAPI.  Mitotic figures for wt and RNAi 
knockdown flies were counted and divided by the number 
of cells in interphase.  RNAi knockdown of Psf2 displays 
decreased numbers of mitotic figures compared to 
wildtype. B) Using EdU incorporation to observe the number 
of cells in S phase in 3rd instar wandering larval brains 
reveals and increased number of cells in S phase in the RNAi 
knockdown flies compared to wildtype (green). 
A 
B RNAi +/+ 
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Sld5 respectively to either the Gal4 activating domain or the Gal4 binding domain.  Psf2 and Sld5 in their 
respective vectors were transformed into the AH109 mutant yeast strain, and plated on media 
supplemented with histidine as a control, and on media lacking histidine to indicate an interaction. A 
physical interaction between Psf2 and Sld5 would lead to the recruitment of the RNA polymerase 
allowing transcription to occur on media lacking histidine.  Yeast was grown at 30oC for 2 days, where 
growth of the yeast strain occurred on the plate lacking His, confirming the previous data of the Psf2-
Sld5 interaction (Figure 17).  
 Mcm2-7 is a 6 subunit complex originally identified in S. cerevisiae that binds DNA in early G1 
phase.  After phosphorylation, the helicase activity of the Mcm2-7 complex is activated (10).  
Additionally, the GINS complex, in conjunction with Cdc45, has been implicated in increasing the 
helicase activity of the Mcm2-7 complex (1).  Since the GINS complex is assumed to interact with Mcm2-
7, we wanted to test the interaction between Psf2 and other subunits of the MCM complex.  Using the 
same method previously discussed, we found a novel interaction between Psf2 and Mcm2 (Figure 17). 
In addition to testing for physical interaction between the different proteins, we also used a semi-
quantitative approach to test for the strength of interaction between each protein.  Using a 5 fold 
dilution of a 2 day overnight yeast culture, the yeast was grown out to 6 dilutions.  The interaction 
between Mcm2 and Psf2 was strong, visible in the growth all the way to the 6th serial dilution, while the 
interaction between Sld5 and Psf2 was slightly weaker only growing the 4th serial dilution (Figure 17).   
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V. Discussion 
 Identification of a Psf2 mutant fly line with a C-terminal truncation has helped to provide insight 
into the complications of removal of that last alpha helical region responsible for Psf2-Psf3 interaction 
(18).  Since the Psf2 homozygous mutant contains two copies of the mutated allele, it is hypothesized 
that the GINS complex is incapable of forming, preventing the completion of DNA replication, and the 
inability of the cell to survive.  Our data supports this hypothesis since homozygous Psf2 mutants arrest 
during late embryonic development after the levels of Psf2 from maternal loading are exhausted.  
Curiously, these cells seem to be arresting in M phase of the cell cycle, contrary to the fact that the 
removal of GINS leads to a stalled replication fork, and the downregulation of GINS leads to an S phase 
delay (32).  However, previous research on other replication proteins, such as Cdc6, has shown that the 
CM-Leu-Trp CM-Leu-Trp-His 
Empty 
Sld5 
Mcm2 
Cdc45 
Psf2 
pGAD Psf2 
pGBK 
Figure 17. Yeast Two-Hybrid Analysis of Psf2 Interactions.  Yeast two-hybrid assay for 
interaction displays interactions with Psf2 and Sld5, Mcm2.  Control plated on media 
supplemented with Histidine (left column) shows growth for each of the vectors.  Experimental 
plated on media lacking Histidine shows growth only with interacting proteins.  Psf2 tested with 
empty pGBK vector as a negative control.  Serial dilutions give insight into the strength of the 
interaction with Mcm2 growing out to the 6th serial diluation with Sld5 displaying a slightly 
weaker interaction with Psf2.   
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cell cycle will still progress through S phase without the complete replication of the genome, causing an 
M phase arrest (33).   
Analysis of homozygous Psf2 mutant early embryos displays asynchronous nuclei at the 
periphery, indicating a defect in either M phase or S phase of the cell cycle.  Since Psf2 is a replication 
protein, removal of the interaction domain between Psf2 and Psf3 could lead to malformation of the 
GINS complex and a defect in S phase of the cell cycle: visible through these asynchronous nuclei.  
Additionally, the presence of anaphase bridges in the early embryos reinforces the idea that the cell 
cycle is progressing before the completion of DNA replication, and moving into an unsuccessful M 
phase. 
 Since Psf2 is involved in DNA replication throughout S phase of the cell cycle, removal of Psf2 
should lead to a significant S phase delay (32).  However, observation of regular cycling larval brain in 
heterozygous mutants reveals an M phase delay.  Additionally, defects in mitotic figures such as 
aneuploidy and broken chromosomes all point to problems during mitosis.  Some replication proteins 
such as ORC and Cdc6 have been shown to display defects in chromosome dynamics during mitosis due 
to the incomplete replication of the chromosomes (33).  Another possible scenario deals with the 
regulation of the progression of DNA replication during S phase.  After the orientation of the replication 
machinery, multiple proteins such as Chk1, Rad53 (yeast analogue of Chk2), and Mec1 are active during 
S phase with multiple functions.  One of these functions is to retard the progression of the replication 
fork.  This allows for the replication forks that are activated later in S phase to complete replication 
before exiting S phase (34).  Since many of the abnormal phenotypes present in the Psf2 mutant are 
defects in M phase, contrary to fact that Psf2 is a replication protein present in S phase, it is possible 
that Psf2 interacts with one of these checkpoint proteins during replication.  Therefore, the inhibition of 
this interaction in the mutant could prevent the retardation of S phase, and the entry into mitosis before 
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complete replication.  Additionally, heterochromatin is replicated late in S phase and typically resides 
around centromeres, which are key mitotic components, so early entry into mitosis could lead to 
decreased replication of these centromeres, causing the incomplete separation of sister chromatids 
resulting in aneuploidy and broken chromosome arms.  All of which are defects in S phase of the cell 
cycle that manifest as phenotypic abnormalities during M phase. 
 Since the heterozygous mutant appears to display defects in S phase that appear as phenotypic 
abnormalities during M phase, observation of tissues that undergo multiple S phases without mitosis 
could prove useful in diagnosing the role of Psf2 during replication.  Absence of any replication 
machinery would prove restrictive in the amount of replication in these tissues visible in the size of the 
nuclei.  Observation of endoreplicating tissue in the heterozygous mutants confirms this hypothesis that 
Psf2, as a replication protein, is essential for endoreplicating tissue to adequately increase their genomic 
content.  The decreased size of the polytene chromosomes in the salivary tissue of the larvae, as well as 
the decreased size and abnormal shape of the nurse cells in the heterozygous Psf2 mutant point to a 
pivotal role for Psf2 and GINS in endoreplicating tissue.  Also, the inability of the nurse cell 
chromosomes to decondense after the characteristic 5-blob stage hints at a role for Psf2 and GINS in 
chromosome decondensation (30).  Again, all phenotypic abnormalities of the Psf2 mutant point to 
possible defects during S phase of the cell cycle, which would be expected from a replication protein. 
 Since the Psf2 mutant is homozygous lethal, most of the phenotypic analysis has been 
performed in heterozygous mutants.  Using of the Gal4 driven RNAi knockdown of Psf2 in larval brains, 
complete knockdown of Psf2 leads to an S phase delay.  Since it is hypothesized that the phenotypic 
abnormalities observed in the heterozygous mutant are a result of the entry into mitosis before 
complete replication of the genome, indicating Psf2 to be a poision subunit, complete knockdown of 
Psf2 was expected to demonstrate the same results.  Since these results are opposite of what was seen 
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in the heterozygous mutant, this presents a few possibilities for the role of Psf2 throughout the cell 
cycle, specifically referring to the function of the C-terminal (Figure 18). 
 First, the C-terminal truncation does not remove the entire interaction domain between Psf2 
and Psf3, so the interaction may simply be weakened.  This weak interaction between Psf2 and Psf3 
decreases the efficiency of the GINS complex, and replication persists at a slower rate (Figure 18a).  
Secondly, the C-terminal truncation completely removes the interaction domain between Psf2 and Psf3, 
but the phenotypes observed are only in heterozygous animals.  The inability of Psf2 and Psf3 to interact 
is imperative to the proper formation of GINS, so the differing results between an M phase and an S 
phase delay is a dosage effect (Figure 18b).  Thirdly, the Psf2-Psf3 interaction domain is completely 
removed, but the interaction between Psf2 and Psf3 is not required for proper GINS formation.  
However, this is unlikely since many previous researchers have identified an interaction domain 
between Psf2 and Psf3, and removal of any of the subunits of GINS results in nonfunctional complex.  On 
the contrary, other previous research has identified fewer interaction domains between Psf2 and other 
subunits, and propose a horseshoe shaped structure as opposed to the ring shaped (36).  Finally, the 
entirety of the interaction domain has not been removed, Psf2 and Psf3 still interact, and the GINS 
complex is formed (Figure 18c). Both of these scenarios implicate the C-terminal domain of Psf2 to have 
functional relevance elsewhere in the cell cycle.  
33 
 
 
 
 
 
Previous research in yeast and human tissue cultures has implicated Psf2 to interact with 
chromosome segregation proteins such as INCENP, Aurora B, and Survivin (4).  This research into the 
role of Psf2 in human chromosome segregation demonstrated the necessity for Psf2 throughout mitosis.  
siRNA knockdown of Psf2 in human tissue culture cells observed throughout M phase resulted in a 2 
hour M phase delay compared to wildtype, and missegregation of proteins aligned at the metaphase 
plate (4).  Additionally, Psf2 was hypothesized to play a role in the attachment of kinetochores to spindle 
fibers: a function relating to the role of Survivn during mitosis (4). If one of these interaction domains 
Figure 18. Schematic Model of Possible Psf2 Mutant Scenarios a) The interaction 
between Psf2 and Psf3 is weakended due to the C-terminal truncation, leading to decreased 
efficiency of GINS. b) The C-terminal truncation inhibits the formation of GINS, but most of 
the phenotypic abnormalities have been observed in heterozygous mutants.  Therefore the 
differing results are due to a dosage defect. c) The C-terminal truncation does not affect the 
formation of GINS, implicating a role for the C-terminal of Psf2 elsewhere in the cell. 
A 
B C 
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lies in the C-terminal region truncated in the Psf2 mutant, this could result in the inability of the 
chromosomes to properly segregate during mitosis.  This could account for the aneuploidy and 
chromosome arm breaks seen in larval brain tissue.  Many other replication proteins such as Orc6, Orc2 
and Hsk1 have been shown to play dual roles in replication through origin localization and firing, as well 
as maintaining centromere cohesion of sister chromatids to allow for accurate segregation (37, 38).  
Therefore, it is likely that Psf2 by itself, or GINS as a functioning complex, also plays a role in mitosis 
through kinetochore maintenance. 
 Additionally, in humans, Psf2 has been shown to interact with Chk2.  Chk2 plays multiple roles 
throughout the cell cycle as a checkpoint protein (39, 40).  Chk2 is activated during DNA damage to 
prevent the entry into both M phase and S phase of the cell cycle before DNA damage repair (39, 40).  
Multiple proteins have been recently identified that are involved in the repair of DNA damage.  Any 
damage occurring prior to the initiation of replication prevents the passage into S phase of the cell cycle 
(38).  However, damage to DNA during S phase results in the stalling of replication forks for repair, and 
inhibited entry into mitosis (38).  If the interaction between Psf2 and Chk2 triggers the stalling of 
replication forks during DNA damage, inhibition of the interaction between these two proteins would 
fail to retard or stall the replication fork, and the cell would progress into mitosis.  This would lead to 
multiple complications later in the cell cycle such as an M phase delay or cell death.  The resulting 
defects in M phase of the cell cycle visible in the heterozygous C-terminal mutant could result from 
inhibited interaction between Psf2 and Chk2.   
The accurate formation of the GINS complex is essential for the completion of DNA replication, 
and progression through the cell cycle (1).  Psf2, as a member of the GINS complex, is imperative for this 
formation, and essential in maintaining genomic stability (16).  Additionally, as seen in the truncation 
mutant, the C-terminal domain of Psf2 is vital for viability, either as a crucial domain for interactions 
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between each subunit within the GINS complex, or through essential interactions elsewhere in the cell 
cycle. 
VI. Conclusion 
 Previous research into the role of Psf2 during S phase and throughout the cell cycle has been 
briefly studied in many human tissue cultures and yeast.  However, this is the first in vivo approach to 
characterize the result of a C-terminal truncation of the Psf2 protein.  Through multiple analyses, Psf2 
has been shown to play a role in M phase, either through a defect in the formation of the GINS complex 
and accurate completion of replication, or through a separable role in chromosome segregation and 
DNA damage checkpoint controls.  Additionally, yeast two hybrid analysis has confirmed the previous 
interaction observed between Psf2 and Sld5, while introducing a novel interaction between Psf2 and 
Mcm2, a member of the Mcm2-7 helicase. 
 Further research into the role of Psf2 through its interactions with other proteins such as Chk2, 
Survivin and Mcm2 would provide useful information in diagnosing the role of Psf2 throughout the cell 
cycle.  Moreover, the specific role of Psf2 is crucial in understanding the functioning of the GINS 
complex, and its purpose throughout S phase.  DNA replication is an intricate process that is still poorly 
understood.   Likewise, defects in the process of replication initiation, elongation and termination create 
the root of many disease states such as cancer (21).  Further insight into the role of the replication 
machinery could prove useful in the diagnoses and treatment of many diseases.  
 
 
 
36 
 
VII.   References 
1. GINS, a novel multiprotein complex required for chromosomal DNA replication in budding 
yeast.(2003). Genes & Development, 17(9), 1153-1165. 
2. Tye, B. K. (2000). Insights into DNA replication from the third domain of life. Proceedings of the 
National Academy of Sciences of the United States of America, 97(6), 2399.  
3. DNA polymerase alpha, a component of the replication initiation complex, is essential for the 
checkpoint coupling S phase to mitosis in fission yeast.(1995). Journal of Cell Science, 108(9), 
3109-18. 
4. Huang, H. (2005). Suppressors of Bir1p (survivin) identify roles for the chromosomal passenger 
protein Pic1p (INCENP) and the replication initiation factor Psf2p in chromosome segregation. 
Molecular and Cellular Biology, 25(20), 9000-9015. 
5. Assembly of a complex containing Cdc45p, replication protein A, and Mcm2p at replication 
origins controlled by S-phase cyclin-dependent kinases and Cdc7p-Dbf4p kinase.(2000). 
Molecular and Cellular Biology, 20(9), 3086-96. 
6. Sclafani, R. A. Cell cycle regulation of DNA replication. Annual Review of Genetics, 41, 237-280. 
7. First the CDKs, now the DDKs.(1999). Trends in Cell Biology, 9(7), 249-252.  
8. Sheu, Y., & Stillman, B. (2010). The Dbf4–Cdc7 kinase promotes S phase by alleviating an 
inhibitory activity in Mcm4. Nature, 463(7277), 113-117. 
9. Bauerschmidt, C., Pollok, S., Kremmer, E., Nasheuer, H., & Grosse, F. (2007). Interactions of 
human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases α and ε 
during S phase. Genes to Cells, 12(6), 745-758. 
37 
 
10. Yoshiki, Y., Takuro, N., & Hisao, M. (2004). A novel intermediate in initiation complex assembly 
for fission yeast DNA replication. Molecular Biology of the Cell, 15(8), 3740-50. 
11. Christensen. T.W., & Tye. B.K. (2003). Drosophila MCM10 interacts with members of the 
prereplication complex and is required for proper chromosome condensation. Molecular Biology 
of the Cell, 14(6), 2206-15. 
12. Chattopadhyay, S. (2007). Human Mcm10 regulates the catalytic subunit of DNA polymerase-α 
and prevents DNA damage during replication. Molecular Biology of the Cell, 18(10), 4085-4095. 
13. Kamada, K., Kubota, Y., Arata, T., Shindo, Y., & Hanaoka, F. (2007). Structure of the human GINS 
complex and its assembly and functional interface in replication initiation. Nature Structural and 
Molecular Biology (Formerly Called Nature Structural Biology), 14(5), 388-396. 
14. Aparicio, T., Ibarra, A., & Méndez, J. (2006). Cdc45-MCM-GINS, a new power player for DNA 
replication. Cell Division, 1(1), 18-0. 
15. Grp/DChk1 is required for G2-M checkpoint activation in drosophila S2 cells, whereas 
Dmnk/DChk2 is dispensable.(2005). Journal of Cell Science, 118(9), 1833-42. 
16. De Falco, M., Ferrari, E., De Felice, M., Rossi, M., Hübscher, U., & Pisani, F. M. (2007). The human 
GINS complex binds to and specifically stimulates human DNA polymerase α-primase. EMBO 
Reports, 8(1), 99-103. 
17. Kanemaki, M., Sanchez-Diaz, A., Gambus, A., & Labib, K. (2003). Functional proteomic 
identification of DNA replication proteins by induced proteolysis in vivo. Nature, 423(6941), 720-
725. 
18. Chang, Y. P. (2007). Crystal structure of the GINS complex and functional insights into its role in 
DNA replication. Proceedings of the National Academy of Sciences of the United States of 
America, 104(31), 12685-12690. 
19. Crystal structure of the human GINS complex.(2007). Genes & Development, 21(11), 1316-1321. 
38 
 
20. A key role for the GINS complex at DNA replication forks.(2007). Trends in Cell Biology, 17(6), 
271-278. 
21. Kanemaki, M., & Labib, K. (2006). Distinct roles for Sld3 and GINS during establishment and 
progression of eukaryotic DNA replication forks. The EMBO Journal, 25(8), 1753-1763. 
22. Obama, K., Ura, K., Satoh, S., Nakamura, Y., & Furukawa, Y. (2005). Up-regulation of Psf2, a 
member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma. Oncology 
Reports, 3, 701-6. 
23. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA 
damage.(2007). Science, 316(5828) 
24. Drosophila Chk2 is required for DNA damage-mediated cell cycle arrest and apoptosis.(2001). 
FEBS Letters, 508(3), 394-398.  
25. Walter, B. E., Perry, K. J., Fukui, L., Malloch, E. L., Wever, J., & Henry, J. J. (2008). Psf2 plays 
important roles in normal eye development in xenopus laevis. Molecular Vision, 14, 906-921. 
26. Drosophila melanogaster: The model organism.(2006). Entomologia Experimentalis Et Applicata, 
121(2), 93-103.  
27. CDC6: From DNA replication to cell cycle checkpoints and oncogenesis.(2008). Carcinogenesis, 
29(2), 237-237. 
28. Expression and function of drosophila cyclin a during embryonic cell cycle progression.(1989). 
Cell (Science Direct), 56(6), 957-957. 
29. Zhang, P., & Spradling, A. (1995). The drosophila salivary gland chromocenter contains highly 
polytenized subdomains of mitotic heterochromatin. Genetics, 139, 659-670.  
30. Royzman, I. (1998). S phase and differential DNA replication during drosophila oogenesis. Genes 
to Cells, 3(12), 767-776. 
39 
 
31. Duffy, J. B. (2002). GAL4 system in drosophila: A fly geneticist's swiss army knife. Genesis: The 
Journal of Genetics and Development, 34(1-2), 1-15.  
32. The human GINS complex associates with Cdc45 and MCM and is essential for DNA 
replication.(2009). Nucleic Acids Research, 37(7), 2087-2095. 
33. Lau, E., Zhu, C., Abraham, R. T., & Jiang, W. (2006). The functional role of Cdc6 in S–G2/M in 
mammalian cells. EMBO Reports, 7(4), 425-430. 
34. Tercero, J. A., & Diffley, J. F. X. (2001). Regulation of DNA replication fork progression through 
damaged DNA by the Mec1/Rad53 checkpoint. Nature, 412(6846), 553.  
35. Lee, H. O. (2009). Endoreplication: Polyploidy with purpose. Genes & Development, 23(21), 
2461-2477.  
36. Boskovic, J., Coloma, J., Aparicio, T., Zhou, M., Robinson, C. V., Méndez, J., et al. (2007). 
Molecular architecture of the human GINS complex. EMBO Reports, 8(7), 678-684. 
37. Orc mutants arrest in metaphase with abnormally condensed chromosomes.(2001). 
Development, 128(9), 1697-707. 
38. Raveendranathan, M., Chattopadhyay, S., Bolon, Y., Haworth, J., Clarke, D. J., & Bielinsky, A. 
(2006). Genome-wide replication profiles of S-phase checkpoint mutants reveal fragile sites in 
yeast. The EMBO Journal, 25(15), 3627-3639.  
39.  Drosophila Chk2 is required for DNA damage-mediated cell cycle arrest and apoptosis.(2001). 
FEBS Letters, 508(3), 394-398.  
40. Rad53 regulates replication fork restart after DNA damage in saccharomyces cerevisiae.(2008). 
Genes & Development, 22(14), 1906-1920.  
41. Apger, Jennifer,  Reubens, Michael, Henderson, Laura, Gouge, Catherine A.,  Ilic, Nina, Zhou, 
Helen H.,  and Christensen, Tim W. Multiple Functions for Drosophila Mcm10 Suggested 
40 
 
Through Analysis of Two Mcm10 Mutant Alleles.Genetics 2010; published ahead of print on May 
24, 2010 as doi: 10.1534/genetics.110.117234 
41 
 
VIII.  Appendix I 
Optimization of Psf2 Antibody using Western Blots 
Materials and Methods 
Embryos were collected from wildtype and psf2 mutant fly lines on grape agar plates after 12 hours by 
squirting water on the grape agar (Genesee Scientific™) plate, swirling embryos around with a small 
paint brush, and removing embryos from plate using a p1000 pipette.  Embryos were placed in a 1.5mL 
Eppendorf tube, water was immediately removed, and the embryos were stored at -80oC.  For the 
Western Blot, embryos were removed from storage and 3X SDS PAGE loading buffer was added to the 
embryos to equal a concentration of 55.5 mg/µL.  Embryos were then ground up using a grinder and 
placed in boiling water for 10 minutes.   After 10 minutes, embryos were removed and placed in a 
centrifuge at 13.3 for 5 minutes.  Protein extracted from Psf2 and wildtype embryos was then added to 
a 12% protein gel (Pierce™) in varying amounts: 8µL, 12µL, and 16µL.  5 µL of the EZ Run Pre-stained 
ladder™ (Fisher™) were added to each side of the protein lanes.  Gel was run at 72 volts with 1 X HEPES 
(Pierce™) running buffer (Table 7) until the protein reached the bottom of the gel.  While the gel was 
running, a 6.5 X 8 silicon membrane was covered in methanol until all the white was removed, and 
immersed in Transfer Buffer (Table 8).  After the gel was finished running, 6 pieces of transfer buffer 
soaked blotter paper was placed on the bottom of the transfer machine followed by the membrane, the 
gel, and 6 more pieces of transfer soaked blotter paper.  Transfer of protein from the gel to the 
membrane was run at 33mAmps for 3 hours.  Once transferred, the membrane was placed in a blocking 
solution (10% milk in Washing Buffer) for 1 hour.  After blocking, membrane was placed in primary 
antibody solution (1:50 anti-Psf2 Chicken (Pacific Immunology™) in 10% milk solution) and incubated at 
4oC overnight.  Following primary antibody incubation, membrane was removed and placed in the 
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Washing Buffer (Table 9) for 3 hours, changing the Buffer every 30 minutes.  After washing the primary 
antibody, the membrane was placed in the secondary antibody solution (1:5000 anti-Chick (Millipore™) 
conjugated to HRP in 10% milk solution) and incubated at 4oC for 45 minutes.  After 45 minutes, 
secondary antibody solution was washed in Washing Buffer for 2 hours, changing solution every 30 
minutes.  After washing, Membrane was placed in HRP chemiluminescent solution (Millipore™) for 1 
minute.  Membrane was then placed between two transparencies and imaged at a 45 minute exposure 
time. 
Results: Psf2 antibody revealed the presence of Psf2 in both wildtype and heterozygous Psf2 mutants.  
However, nonspecific binding and decreased affinity made it difficult to determine if the truncated Psf2 
was present in the mutant (Figure 19). 
                    
Component Amount Added 
Tris Base 121 g 
HEPES™ (Pierce™) 238 g 
SDS 10 g 
Figure 19. Western Blot of Psf2  Psf2 antibody 
detected Psf2 protein present in wildtype and 
heterozygous mutant. 
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dH20 to 1000 mL 
 
Component Amount Added 
Tris Base 5.8 g 
Glycine 2.9 g 
10% SDS 3.7 mL 
MetOH 200 mL 
dH20 to 1000 mL 
 
Component Amount Added 
10X PBS 100 mL 
Tween-20 2 mL 
dH20 to 1000 mL 
 
 
 
Table 7. Components of 10X HEPES Running Buffer.  Diluted to 1X for use 
Table 8. Components of Transfer Buffer 
Table 9. Components of Washing Buffer 
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IX.  Appendix II 
Mcm10 Mutations cause defects in chromosome condensation visible in Drosophila Ovaries 
Materials and Methods 
Ovary/Follicle Dissection and Imaging: Female fly stocks of Mcm10scim19 homozygous mutant and 
Mcm10d08029 homozygous mutant 3-7 days post eclosion were fed for 2 days with a 1:1 mixture of active 
dry yeast and dH20.  Random female flies were selected, and ovaries were dissected out in a dual 
concavity slide in one well with 50 μL 1X PBS.  Ovarioles were teased apart using a needlepoint tool, 
moved to the second well, and fixed for 20 minutes in a 4% Formaldhyde in PBX (PBS with 1% Triton X-
100).  After fixing, ovaries were moved to a new well and stained for 5 minutes in a 1 µg/ml DAPI in PBS.  
Ovaries were then washed 3X in PBX, followed by a 1 hour PBX wash, and 3X 10 minute washes in PBX.  
Ovaries were then moved using Dumoxel™ Tweezers #5 (Electron Microscopy Sciences™) to a clean 
Lifterslip™ (Thermo Scientific™), mounted with Vectashield™ (Vector™) and imaged using confocal 
optical sectioning microscopy.  
Results:  Jennifer Apger, Michael Reubens, Laura Henderson, Catherine A. Gouge, Nina Ilic, Helen H. 
Zhou, and Tim W. Christensen. Multiple Functions for Drosophila Mcm10 Suggested Through Analysis of 
Two Mcm10 Mutant Alleles.Genetics 2010; published ahead of print on May 24, 2010 as doi: 
10.1534/genetics.110.117234 (Figure 20).       
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 Figure 20. Condensation Defects Visualized in Mcm10 Mutant Ovarioles. Analysis of ovaries in 
Mcm10scim19 homosygous mutant revealed an inability to decondense from the 5 blob stage compared to 
wildtype.  However, the homozygous truncation mutant, Mcm10d08029, progressed through the stages of 
development with no defects.( Jennifer Apger, Michael Reubens, Laura Henderson, Catherine A. Gouge, Nina 
Ilic, Helen H. Zhou, and Tim W. Christensen. Multiple Functions for Drosophila Mcm10 Suggested Through 
Analysis of Two Mcm10 Mutant Alleles.Genetics 2010; published ahead of print on May 24, 2010 as doi: 
10.1534/genetics.110.117234 ) 
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  X. Appendix III 
RNAi knockdown of Psf2 leads to defects in formation of Drosophila eyes 
Materials and Methods 
RNAi knockdown of Psf2 in eye tissue of flies was initiated by crossing Psf2 RNAi line virgins with the GAL 
4 driver for RNAi knockdown in eye tissue.  F1 progeny were observed under a dissecting light 
microscope for phenotypic abnormalities.  Flies exhibiting defects in eye formation were frozen and 
observed through scanning electron microscopy. Psf2/CyO mutant fly lines were also observed under a 
dissecting light microscope, and random female and male flies were chosen for observation through 
scanning electron microscopy for comparison. 
Results 
Psf2/CyO mutants displayed no visible defects in eye development (Figure 21a).  RNAi knockdown of 
Psf2 in eye tissue displays defects in eye development.  A mutated area appears on the ventral side of 
the left eye, forcing the eye to be located more towards the dorsal side of the head (Figure 21b).  
Additionally, there is an extra antennae located on the anterior of the head (Figure 21c), as well as 
mutated bristles (Figure 21d). 
      A 
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B 
D C 
Figure 21. Mutated Eye Region Resulting from Psf2 RNAi Knockdown. a) 
Psf/CyO flies display no defects in eye development.  b) RNAi knockdown of Psf2 in eye 
tissue displays a mutated area located on the ventral side of the head.  The eye has 
been moved dorsally.  c) Bristles located on the RNAi fly are bent, with irregular groves.  
d) An extra antenna appears on the anterior of the head in the RNAi flies. 
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XI.   Appendix IV 
Generation of Psf2 null mutant flies using imprecise p-element excision 
Null mutant flies were generated using the cross seen in Figure 22.  Final stocks were observed to see if 
you curly was lost. 
 
 
Results: 7 lines were unable to lose the curly balancer, but further analysis is necessary to determine if 
there is a Psf2 null mutation. 
 
Figure 22. Generation of a Psf2 null mutant 
using imprecise p-element excision 
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XII.   Appendix V 
Generation of double mutant flies 
Materials and Methods 
The Psf2-Psf1 double mutant fly was generated as seen in Figure 23. 
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The Psf2-Sld5 double mutant fly was generated as seen in Figure 24. 
 
 
Figure 23.  Generation of Psf2-Psf1 double 
mutant fly 
51 
 
 
 
The Psf2-Mcm2 double mutant was generated as seen in Figure 25. 
 
 
Figure 24.  Generation of Psf2-Sld5 double 
mutant fly 
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Figure 25.  Generation of Psf2-Mcm2 double 
mutant fly 
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XIII.   Appendix VI 
PEV Analysis of Psf2 heterozygous mutant 
Methods: A cross was performed to observe the role of Psf2 in silencing of heterochromatin (Figure 26). 
 
 
Following the cross to the variegating line, flies were scored according the severity of the dumpy 
phenotype, with a built in control.   
Results: The analysis allowed for the determination of the distance from the centromere where 
heterochromatin formation occurred.  The mean dumpy score for the control was 0.344 and the mean 
dumpy score for Psf2 was 0.57 (Figure 27b).  T-test analysis using Minitab™ statistical software showed a 
significant increase in variegation in the Psf2 mutant line with a p-value of .008. 
Figure 26.  Psf2 position effect variegation 
cross 
54 
 
Discussion:   Heterochromatin is replicated late during S phase and contains silenced regions of the 
genomes (41).  Alterations in the formation of heterochromatin can results in changes of genomic 
expression.  Since the psf2 heterozygous mutant reveals an increase in variegation, there is more 
heterochromatin formation occurring in the mutant compared to the control.  This could result from the 
retardation of replication elongation due to decreased levels of the GINS Complex, resulting in an 
increase in late replication of DNA, which leads to increased formation of heterochromatin. 
 
Figure 27. Position Effects Variegation Analysis of Psf2.  Flies 
were scored to reveal and increase in the number of flies expressing 
the dumpy gene, indicating a decrease in the formation of 
heterochromatin.  Statistical analysis revealed an increase in 
variegation in the heterozygous mutant which was statistically 
significant with a p-value of 0.008 
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